4.7 Article

Rejection and fate of trace organic compounds (TrOCs) during membrane distillation

期刊

JOURNAL OF MEMBRANE SCIENCE
卷 453, 期 -, 页码 636-642

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.memsci.2013.12.002

关键词

Trace organic compounds (TrOCs); Direct contact membrane distillation (DCMD); Volatility; Fate and transport; Hydrophobicity/hydrophilicity

资金

  1. Australian Research Council [DP140103864]
  2. University of Wollongong

向作者/读者索取更多资源

In this study, we examined the feasibility of membrane distillation (MD) for removing trace organic compounds (TrOCs) during water and wastewater treatment. A set of 29 compounds was selected to represent major TrOC groups, including pharmaceuticals, steroid hormones, phytoestrogens, UV-filters, industrial chemicals, and pesticides that occur ubiquitously in municipal wastewater. Results reported here suggest that rejection and fate and transport of TrOCs during MD are governed by their volatility and, to a lesser extent, hydrophobicity. All TrOCs with pK(H)>9 (which can be classified as non-volatile) were well removed by MD. Among the 29 TrOCs investigated in this study, three compounds (i.e. 4-tert-octylphenol, 4-tert-butylphenol and benzophenone) possess moderate volatility (pK(H)<9) and therefore had the lowest rejection efficiencies of 54%, 73% and 66%, respectively. The results suggest that the rejection of TrOCs with pK(H)<9 may be governed by the interplay between their hydrophobicity and volatility. In addition, the fate and transport of the TrOCs during the MD process was also investigated. Hydrophilic TrOCs having negligible volatility were concentrated in the feed, while hydrophobic compounds with moderate volatility were substantially lost due to evaporation or adsorption. When MD treatment was integrated with a thermophilic membrane bioreactor (MBR), near complete removal (>95%) of all 29 TrOCs investigated in this study was achieved despite their diverse physicochemical properties (i.e. hydrophobicity, persistency and volatility). The results suggest that MD could be a promising post-treatment to be used in conjunction with thermophilic MBR for TrOC removal. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved,

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据